Posts for Krystal Biotech, Inc. ($KRYS)

Explore Krystal Biotech, Inc.'s impressive financial turnaround with $290.5M revenue and $89.2M net income for 2024. A must-read for biotech investors!

Discover essential insights from Krystal Biotech, Inc.'s 8-K filing on February 19, 2025, covering significant events and updates. Learn more about their corporate developments.

Explore Krystal Biotech's 8-K filing detailing significant corporate events on December 18, 2024. Discover essential insights affecting shareholders and the company's future.